We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
NORVIR Abbvie Pty Ltd
Product name
NORVIR
Sponsor
Accepted date
Oct-2025
Active ingredients
ritonavir
Proposed indication
Norvir (ritonavir) is proposed to be used together with other HIV medicines to increase their effectiveness. It is proposed to be used in adults and children aged 12 and over who have HIV-1.
Application type
C (new indication)
Publication date
Oct-2025